Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 17001-17050 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06673108
Vaginal Photobiomodulation for Chronic Pelvic Pain
PHASE2
Recruiting
126 participants
Started: Oct 17, 2024 · Completed: Jun 30, 2026
2 conditions
2 sponsors
5 locations
NCT06585514
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
PHASE1/PHASE2
Recruiting
18 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06640049
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
PHASE2
Recruiting
23 participants
Started: Oct 17, 2024 · Completed: Apr 15, 2031
1 condition
1 sponsor
8 locations
NCT06562751
Developing an Intervention to Help Nurses Improve Sexual Healthcare in Men With Inflammatory Bowel Disease
N/A
Recruiting
792 participants
Started: Oct 17, 2024 · Completed: May 1, 2026
1 condition
4 sponsors
1 location
NCT06968065
Comparison of Ultrasound-Guided Serratus Combination Plane Blocks and Local Wound Infiltration for Postoperative Analgesia Management in Minimally Invasive Cardiac Surgery (MICS)
NA
Recruiting
60 participants
Started: Oct 17, 2024 · Completed: Jun 30, 2025
3 conditions
1 sponsor
1 location
NCT06685367
The Cost-effectiveness of Artificial Intelligence Acute Kidney Injury Prediction Auxiliary Software (Acura AKI)
NA
Recruiting
3,600 participants
Started: Oct 17, 2024 · Completed: Sep 15, 2025
3 conditions
1 sponsor
1 location
NCT06521918
Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation
N/A
Recruiting
242 participants
Started: Oct 17, 2024 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT06253637
Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program
PHASE2
Recruiting
31 participants
Started: Oct 17, 2024 · Completed: Oct 31, 2029
1 condition
1 sponsor
3 locations
NCT06636318
Immune Status After Being on Call for 24 Hrs
N/A
Recruiting
60 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06489665
Imaging Quality and Potential Clinical Relevance of Phase Contrast Mammography In-vivo: a Single-center, Prospective Study
N/A
Recruiting
350 participants
Started: Oct 17, 2024 · Completed: Sep 1, 2030
3 conditions
3 sponsors
2 locations
NCT06604117
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
N/A
Recruiting
200 participants
Started: Oct 17, 2024 · Completed: Oct 31, 2027
4 conditions
1 sponsor
1 location
NCT06865196
Investigating a Brief Virtual Seminar Series for Parents of Teens Ages 13-17
NA
Recruiting
185 participants
Started: Oct 17, 2024 · Completed: Oct 31, 2025
1 condition
2 sponsors
1 location
NCT06619275
Ripretinib (QINLOCK®) According to Current SmPC
N/A
Recruiting
100 participants
Started: Oct 17, 2024 · Completed: Nov 30, 2027
1 condition
2 sponsors
1 location
NCT06820983
Evaluation of the Quality of Life of Patients with DBB with the Installation of OPEP
NA
Recruiting
60 participants
Started: Oct 17, 2024 · Completed: Apr 30, 2026
3 conditions
2 sponsors
1 location
NCT06730373
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
PHASE2
Recruiting
110 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2027
3 conditions
1 sponsor
20 locations
NCT06597942
Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)
PHASE1/PHASE2
Recruiting
54 participants
Started: Oct 17, 2024 · Completed: Oct 31, 2026
7 conditions
1 sponsor
1 location
NCT06742515
Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
PHASE2
Recruiting
20 participants
Started: Oct 17, 2024 · Completed: Aug 31, 2028
1 condition
1 sponsor
1 location
NCT06726811
Droperidol and QTc Interval Changes in ED Patients
N/A
Recruiting
500 participants
Started: Oct 17, 2024 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT06734013
Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation
NA
Recruiting
40 participants
Started: Oct 17, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06511778
sTErnAl heMostasiS Trial
PHASE4
Recruiting
60 participants
Started: Oct 17, 2024 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT06552091
Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Hormone Therapy
NA
Recruiting
76 participants
Started: Oct 17, 2024 · Completed: Feb 17, 2027
1 condition
1 sponsor
1 location
NCT06795932
Evaluation and Treatment of Adhesive Capsulitis Using Non-invasive Neurostimulation Devices
NA
Recruiting
30 participants
Started: Oct 17, 2024 · Completed: Apr 30, 2027
2 conditions
1 sponsor
1 location
NCT06433310
Understanding the Efficacy of Dietary Supplement on Fungal Mycobiota in Healthy Volunteers: A Pilot Study
PHASE4
Recruiting
20 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2026
5 conditions
1 sponsor
1 location
NCT07066085
Serial Blood Count Study
EARLY_PHASE1
Recruiting
20 participants
Started: Oct 17, 2024 · Completed: Dec 1, 2025
3 conditions
1 sponsor
1 location
NCT06744660
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
NA
Recruiting
1,000 participants
Started: Oct 17, 2024 · Completed: Dec 1, 2025
2 conditions
2 sponsors
3 locations
NCT06645691
Hyperpolarized MR Imaging with Carbon-13 Pyruvate in the Human Body
PHASE2
Recruiting
200 participants
Started: Oct 17, 2024 · Completed: May 31, 2028
5 conditions
2 sponsors
1 location
NCT06706349
Effect of Adapted Physical Activity on Sleep Quality in People with Alcohol Use Disorder
NA
Recruiting
40 participants
Started: Oct 17, 2024 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT06867588
The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)
NA
Recruiting
68 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06643481
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
PHASE2
Recruiting
225 participants
Started: Oct 17, 2024 · Completed: Jun 20, 2028
1 condition
1 sponsor
90 locations
NCT06094478
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
NA
Recruiting
900 participants
Started: Oct 17, 2024 · Completed: Jul 31, 2028
3 conditions
9 sponsors
7 locations
NCT06520124
Stellest Lens Wear in Adult Progressing Myopes
NA
Recruiting
42 participants
Started: Oct 17, 2024 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
NCT06576908
Evaluation of On-Couch CBCT Image Quality
NA
Recruiting
46 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06621329
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
PHASE2/PHASE3
Recruiting
40 participants
Started: Oct 17, 2024 · Completed: Oct 31, 2026
2 conditions
2 sponsors
1 location
NCT06842966
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
PHASE2
Recruiting
300 participants
Started: Oct 17, 2024 · Completed: Dec 31, 2026
2 conditions
1 sponsor
17 locations
NCT07161648
Use of Neuromuscular Electrical Stimulation to Prevent Exercise Resistance
NA
Recruiting
30 participants
Started: Oct 17, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06496373
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
EARLY_PHASE1
Recruiting
20 participants
Started: Oct 16, 2024 · Completed: Jun 30, 2027
2 conditions
2 sponsors
1 location
NCT06549790
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
PHASE1
Recruiting
124 participants
Started: Oct 16, 2024 · Completed: May 15, 2030
1 condition
1 sponsor
7 locations
NCT06760273
Long-term Impact of Inhaled Tobramycin for Pseudomonas Aeruginosa Eradication in Bronchiectasis (ERASE II)
N/A
Recruiting
364 participants
Started: Oct 16, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
58 locations
NCT06662942
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
PHASE1
Recruiting
100 participants
Started: Oct 16, 2024 · Completed: Oct 16, 2025
1 condition
2 sponsors
3 locations
NCT06295471
A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser
NA
Recruiting
23 participants
Started: Oct 16, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06173752
Mechanisms of Exposure Therapy for OCD
NA
Recruiting
400 participants
Started: Oct 16, 2024 · Completed: Apr 30, 2029
1 condition
1 sponsor
2 locations
NCT06572267
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
PHASE2
Recruiting
18 participants
Started: Oct 16, 2024 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT06055959
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
PHASE2/PHASE3
Recruiting
8 participants
Started: Oct 16, 2024 · Completed: Dec 25, 2026
1 condition
1 sponsor
9 locations
NCT06672302
A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients At High Risk for Breast Cancer
N/A
Recruiting
330 participants
Started: Oct 16, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT06691100
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
NA
Recruiting
40 participants
Started: Oct 16, 2024 · Completed: Oct 16, 2027
8 conditions
1 sponsor
1 location
NCT06714838
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
PHASE3
Recruiting
100 participants
Started: Oct 16, 2024 · Completed: Oct 31, 2028
1 condition
4 sponsors
1 location
NCT06432764
Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Patients With Crohn's Disease.
PHASE1
Recruiting
12 participants
Started: Oct 16, 2024 · Completed: Aug 14, 2026
1 condition
1 sponsor
1 location
NCT06643702
Prevalence av BPPV Among Elderly in Primary Care
N/A
Recruiting
115 participants
Started: Oct 16, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06326463
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
PHASE1
Recruiting
24 participants
Started: Oct 16, 2024 · Completed: Jul 1, 2031
5 conditions
1 sponsor
1 location
NCT06539624
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
NA
Recruiting
12 participants
Started: Oct 16, 2024 · Completed: Apr 9, 2027
1 condition
1 sponsor
2 locations
Previous
1
More pages
338
339
340
341
342
343
344
More pages
1333
Next